Speaker illustration

Doctor Yale Mitchel

Rahway ()

Anacetrapib decreases LDL-C in patients with heterozygous familial hypercholesterolemia irrespective of the underlying genetic mutation

Event: ESC CONGRESS 2017

Topic: Lipids (Epidemiology and Prevention)

Session: Lipids

Thumbnail

This platform is supported by

logo Novo Nordisk